World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
54
Citations
11263
World Ranking
3880
National Ranking
1778

John W. Huggins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John W. Huggins sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 97 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John W. Huggins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John W. Huggins sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John W. Huggins is affiliated with the United States Department of the Army in the United States. Their research primarily spans the fields of Immunology and Microbiology, Medicine, and Biochemistry, Genetics, and Molecular Biology. Within these broad fields, they focus on the subfields of Virology, Epidemiology, and Molecular Biology.

The scientist's work revolves around key topics including:

  • Poxvirus research and outbreaks
  • Bacillus and Francisella bacterial research
  • Herpesvirus infections and treatments
  • Virology and viral diseases

John W. Huggins has contributed to multiple publications, with frequent appearances in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Neglected Tropical Diseases
  • Emerging Infectious Diseases
  • Frontiers in Microbiology
  • Pathogens

Recent published papers include:

  • Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo, 2022, bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo, 2023, PLoS Neglected Tropical Diseases
  • Congenital Mpox Syndrome (Clade I) in Stillborn Fetus after Placental Infection and Intrauterine Transmission, Democratic Republic of the Congo, 2008, 2023, Emerging Infectious Diseases
  • Development of a specific MPXV antigen detection immunodiagnostic assay, 2023, Frontiers in Microbiology
  • Design and Optimization of a Monkeypox virus Specific Serological Assay, 2023, Pathogens

The scientist collaborates frequently with other researchers, with the most frequent co-authors being:

  • Phillip R. Pittman
  • Placide Mbala Kingebeni
  • James W. Martin
  • Jean-Jacques Muyembe Tamfum
  • Mary G. Reynolds

Best Publications

  • A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever

    Mike Bray;Kelly Davis;Thomas Geisbert;Connie Schmaljohn

  • Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

    John W. Huggins;Chin Min Hsiang;Thomas M. Cosgriff;Mei Ying Guang

  • Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

    Patricia L. Earl;Jeffrey L. Americo;Linda S. Wyatt;Leigh Anne Eller

  • An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge

    Guang Yang;Daniel C. Pevear;Marc H. Davies;Marc S. Collett

  • Prospects for Treatment of Viral Hemorrhagic Fevers with Ribavirin, a Broad-Spectrum Antiviral Drug

    John W. Huggins

  • Evaluation of Immune Globulin and Recombinant Interferon-α2b for Treatment of Experimental Ebola Virus Infections

    Peter B. Jahrling;Peter B. Jahrling;Peter B. Jahrling;Thomas Geisbert;Thomas Geisbert;J. B. Geisbert;J. B. Geisbert;J. R. Swearengen;J. R. Swearengen

  • Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo.

    Placide K Mbala;John W Huggins;Therese Riu-Rovira;Steve M Ahuka

  • Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections.

    Robert O Baker;Mike Bray;John W Huggins

  • Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances.

    Bjarne Gabrielsen;Bjarne Gabrielsen;Thomas P. Monath;John W. Huggins;Deborah F. Kefauver

  • Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo.

    Jeffrey R. Kugelman;Sara C. Johnston;Prime M. Mulembakani;Neville Kisalu

  • Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus Challenge

    Mike Bray;Mark Martinez;Donald F. Smee;Debbie Kefauver

  • Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening

    Jonathan S. Towner;Jason Paragas;Jason E. Dover;Manisha Gupta

  • Interferon-β 1a and SARS Coronavirus Replication

    Lisa E. Hensley;Elizabeth A. Fritz;Peter B. Jahrling;Christopher L. Karp

  • Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

    P. B. Jahrling;J. Geisbert;J. R. Swearengen;G. P. Jaax

  • Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.

    Alexander G. Pletnev;Michael Bray;John Huggins;Ching-Juh Lai

  • DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.

    Lorna Vanderzanden;Mike Bray;Deborah Fuller;Tim Roberts

  • Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.

    J J Kirsi;J A North;P A McKernan;B K Murray

  • Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus.

    M. Bray;S. Hatfill;L. Hensley;J.W. Huggins

  • Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-l-homocysteine hydrolase inhibitor ☆

    Mike Bray;John Driscoll;John W. Huggins

  • Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox

    Peter B. Jahrling;Lisa E. Hensley;Mark J. Martinez;James W. LeDuc

Frequent Co-Authors

Mike Bray
Mike Bray National Institutes of Health
Robert W. Sidwell
Robert W. Sidwell Utah State University
Donald F. Smee
Donald F. Smee Utah State University
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Thomas W. Geisbert
Thomas W. Geisbert The University of Texas Medical Branch at Galveston
Inger K. Damon
Inger K. Damon Centers for Disease Control and Prevention
David A. Relman
David A. Relman Stanford University
James W. LeDuc
James W. LeDuc The University of Texas Medical Branch at Galveston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often requires a strong foundation in healthcare and biological sciences. For those interested in expanding their clinical skills alongside immunology knowledge, exploring accelerated FNP programs can be a strategic choice. These programs are designed for registered nurses aiming to become family nurse practitioners more quickly, allowing for advanced patient care roles that frequently overlap with immunology specialties.

If you're new to nursing but aspire to dive into this field, considering the best online BSN programs for non nurses provides a flexible entry point. These degrees tailor education to help non-nurses gain essential knowledge and clinical experience, forming a solid base for immunology-related roles in healthcare settings.

For students eager to fast-track their career, 12-month accelerated nursing programs offer intense, immersive training that can lead to quicker qualification as a registered nurse. This pathway helps launch careers that support various immunology research or clinical applications.

Furthermore, exploring LPN schools easy to get into is ideal for those seeking entry-level roles in patient care with relatively low barriers to entry. Licensed Practical Nurses often support immunology departments, enhancing patient monitoring and care within clinical environments.

Best Scientists Citing John W. Huggins

Trending Scientists

Recently Published Articles